Celon Pharma SA banner

Wall St Price Targets

CLN Price Forecast
Based on 6 analysts

+27% Upside
from zł15.98 today

Celon Pharma SA (CLN)’s 12-month stock price forecast through November 2027 has a consensus target of zł20.25, implying 27% upside. The forecast is based on price targets from 6 Wall Street analysts.

CLN Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CLN yet.

Celon Pharma SA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLN's stock price target?
Price Target
20.25 PLN

According to Wall Street analysts, the average 1-year price target for CLN is 20.25 PLN with a low forecast of 16.16 PLN and a high forecast of 26.46 PLN.

What is the Revenue forecast for Celon Pharma SA?
Projected CAGR
13%

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Celon Pharma SA?
Projected CAGR
19%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next -4 years is 19%.

Back to Top